264 related articles for article (PubMed ID: 32697896)
21. CLINICAL, LABORATORIAL AND EVOLUTIONARY ASPECTS OF PEDIATRIC PATIENTS WITH LIVER DISEASE DUE TO ALPHA 1-ANTITRYPSIN DEFICIENCY.
Costa MP; Ferreira AR; Rodrigues AT; Fagundes EDT; Queiroz TCN
Arq Gastroenterol; 2023; 60(4):438-449. PubMed ID: 38018549
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Alpha-1 Antitrypsin Deficiency, Self-Reported Behavior Change, and Health Care Engagement Among Direct-to-Consumer Recipients of a Personalized Genetic Risk Report.
Ashenhurst JR; Nhan H; Shelton JF; Wu S; Tung JY; Elson SL; Stoller JK;
Chest; 2022 Feb; 161(2):373-381. PubMed ID: 34656525
[TBL] [Abstract][Full Text] [Related]
23. Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis.
Al-Jameil N; Hassan AA; Buhairan A; Hassanato R; Isac SR; Al-Otaiby M; Al-Maarik B; Al-Ajeyan I
Medicine (Baltimore); 2017 Feb; 96(6):e6071. PubMed ID: 28178162
[TBL] [Abstract][Full Text] [Related]
24. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
25. Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype.
Chen VL; Burkholder DA; Moran IJ; DiBattista JV; Miller MJ; Chen Y; Du X; Oliveri A; Cushing KC; Lok AS; Speliotes EK
JHEP Rep; 2022 Jun; 4(6):100483. PubMed ID: 35571533
[TBL] [Abstract][Full Text] [Related]
26. Alpha1-antitrypsin deficiency: New therapies on the horizon.
Remih K; Amzou S; Strnad P
Curr Opin Pharmacol; 2021 Aug; 59():149-156. PubMed ID: 34256305
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
Strnad P; Buch S; Hamesch K; Fischer J; Rosendahl J; Schmelz R; Brueckner S; Brosch M; Heimes CV; Woditsch V; Scholten D; Nischalke HD; Janciauskiene S; Mandorfer M; Trauner M; Way MJ; McQuillin A; Reichert MC; Krawczyk M; Casper M; Lammert F; Braun F; von Schönfels W; Hinz S; Burmeister G; Hellerbrand C; Teufel A; Feldman A; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Ridinger M; Wodarz N; Soyka M; Rietschel M; Kiefer F; Weber T; Marhenke S; Vogel A; Hinrichsen H; Canbay A; Schlattjan M; Sosnowsky K; Sarrazin C; von Felden J; Geier A; Deltenre P; Sipos B; Schafmayer C; Nothnagel M; Aigner E; Datz C; Stickel F; Morgan MY; Hampe J; Berg T; Trautwein C
Gut; 2019 Jun; 68(6):1099-1107. PubMed ID: 30068662
[TBL] [Abstract][Full Text] [Related]
28. Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection.
Schuler BA; Bastarache L; Wang J; He J; Van Driest SL; Denny JC
PLoS One; 2023; 18(8):e0286469. PubMed ID: 37651384
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center.
Kueppers F
Respir Med Case Rep; 2021; 32():101345. PubMed ID: 33552892
[TBL] [Abstract][Full Text] [Related]
30. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
[TBL] [Abstract][Full Text] [Related]
31. Liver disease in adults with α1-antitrypsin deficiency.
Mandorfer M; Bucsics T; Hutya V; Schmid-Scherzer K; Schaefer B; Zoller H; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Ferenci P; Kneussl M; Reiberger T
United European Gastroenterol J; 2018 Jun; 6(5):710-718. PubMed ID: 30083333
[TBL] [Abstract][Full Text] [Related]
32. Characterization of hepatic inflammatory changes in a C57BL/6J mouse model of alpha1-antitrypsin deficiency.
Khodayari N; Oshins R; Aranyos AM; Duarte S; Mostofizadeh S; Lu Y; Brantly M
Am J Physiol Gastrointest Liver Physiol; 2022 Dec; 323(6):G594-G608. PubMed ID: 36256438
[TBL] [Abstract][Full Text] [Related]
33. Clinical considerations in individuals with α
McElvaney GN; Sandhaus RA; Miravitlles M; Turino GM; Seersholm N; Wencker M; Stockley RA
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32165400
[TBL] [Abstract][Full Text] [Related]
34. The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes.
Nakanishi T; Forgetta V; Handa T; Hirai T; Mooser V; Lathrop GM; Cookson WOCM; Richards JB
Eur Respir J; 2020 Dec; 56(6):. PubMed ID: 32675199
[TBL] [Abstract][Full Text] [Related]
35. SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.
Franciosi AN; Carroll TP; McElvaney NG
Thorax; 2021 Mar; 76(3):298-301. PubMed ID: 32917839
[TBL] [Abstract][Full Text] [Related]
36. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency.
Janciauskiene S; Wallmark A; Piitulainen E; Köhnlein T; Welte T; Sveger T
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):716-20. PubMed ID: 21617532
[TBL] [Abstract][Full Text] [Related]
37. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
38. Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of
Seixas S; Marques PI
Appl Clin Genet; 2021; 14():173-194. PubMed ID: 33790624
[TBL] [Abstract][Full Text] [Related]
39. Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients.
Nygren D; Mölstad U; Thulesius H; Hillman M; Broman LM; Tanash H; Landin-Olsson M; Rasmussen M; Thunander M
Int J Gen Med; 2022; 15():5843-5848. PubMed ID: 35789772
[TBL] [Abstract][Full Text] [Related]
40. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease.
Chappell S; Hadzic N; Stockley R; Guetta-Baranes T; Morgan K; Kalsheker N
Hepatology; 2008 Jan; 47(1):127-32. PubMed ID: 17972336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
